- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Regulation 2(5)
Regulation 2(1)
Column 1 | Column 2 | Column 3 |
---|---|---|
Drug | Patient | Purpose |
Acetylcysteine Granules | Any patient | Treatment of abdominal complications associated with cystic fibrosis |
Carbocisteine | A patient under the age of 18 who has undergone a tracheostomy | Treatment of any condition which, through damage or disease, affects the airways and has required a tracheostomy |
Clobazam | Any patient | Treatment of epilepsy |
Pregnavite Forte F Tablets | A woman who has previously given birth to a child (whether or not born alive) with a defect of the neural tube or aborted a foetus with such a defect | Reduction of the risk of spina bifida or anencephaly in a child which may be born to the patient |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: